Physician profile
Robert Turoff
NPI 1316943459
$1,520.69
in general payments reported to CMS, 2019-2025
13 companies · $24.22 in 2025
The $24.22 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $82.10 · 2021: $277 · 2022: $396 · 2023: $260 · 2024: $188 · 2025: $24.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $651.96 | 2021-2024 | Signia, Interstim |
| Smith+Nephew, INC. | $217.41 | 2019-2023 | Collagenase Santyl |
| Cumberland Pharmaceuticals, INC. | $178.38 | 2019-2024 | Caldolor |
| Olympus America INC. | $125.00 | 2019 | |
| Hologic INC | $122.72 | 2022 | |
| Thd America, INC. | $83.12 | 2023 | |
| Innocoll Pharmaceuticals Limited | $29.58 | 2021-2022 | |
| Exact Sciences Corporation | $24.22 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.23 | 2022 | |
| Axonics, INC. | $19.94 | 2020 | |
| Convatec INC. | $17.07 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.48 | 2021 | |
| Ethicon US, LLC | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Turoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.